Here are relevant reports on : gastroenterology-telemedicine-market

• Gastroenterology Market - Global Forecast to 2030

  The gastroenterology market is expected to experience steady growth in the coming years. Gastroenterology is the branch of medicine that focuses on the diagnosis, treatment, and management of disorders and diseases related to the gastrointestinal (GI) tract, which includes the stomach, intestines, liver, pancreas, and esophagus.

  • Published: May 2026
  • Price: $ 4950
  • TOC Available:

• Enteral Feeding Formulas Market by Product (Polymeric, Elemental, Disease-specific), Stage (Adults, Pediatrics), Application (Oncology, Gastroenterology, Neurology, Hypermetabolism), End User (Hospitals, LTCF, Home care) & Region - Global Forecast to 2027

  The global enteral feeding formulas market growth is primed to transition from $5.2 billion in 2022 to $8.2 billion by 2027, showcasing a strong CAGR of 9.5%. Factors such as rising healthcare expenditure; a surge in the number of preterm births worldwide; growing aging population in need for enteral feeding; rising prevalence of chronic diseases such as diabetes, cancer, gastrointestinal diseases, and neurological disorders; growing awareness of enteral nutrition benefits; and rapid improvements in healthcare facilities in emerging countries are expected to further drive the market during the forecast period.

  • Published: August 2022
  • Price: $ 4950
  • TOC Available:

• Diagnostic Catheter Market by Type (Angiography, OCT, Ultrasound, Electrophysiology, Pressure and Hemodynamic Monitoring), Application Area (Cardiology, Urology, Neurology, Gastroenterology), End User (Hospitals, Imaging Centers) - Global Forecast to 2021

  The global diagnostic catheters market is projected to grow at a CAGR of around 7.3%. The diagnostic catheters market comprises a network of players involved in the research and product development; raw material supply; medical device manufacturing; distribution and sale; and post-sales services. The major players in the global market are Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (U.S.), Medtronic plc. (Ireland), Johnson & Johnson (U.S.), Koninklijke Philips N.V. (The Netherlands), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (U.S.), C. R. Bard, Inc. (U.S.), Edward Lifesciences Corporation (U.S.), and Terumo Corporation (Japan).

  • Published: January 2017
  • Price: $ 4950
  • TOC Available:

• Gastrointestinal Products Market | Gastroenterology Products Market by Devices (Endoscopy, Ablation system, Motility testing, Biopsy devices, Stenting devices, pH monitoring), Diseases (GERD), (IBD), Gastrointestinal cancer), End-User (Hospitals, ASC) - Global Forecast to 2029

  The global gastrointestinal products market, valued at US$13.8 million in 2023, stood at US$14.7 million in 2024 and is projected to advance at a resilient CAGR of 6.1% from 2024 to 2029, culminating in a forecasted valuation of US$19.7 million by the end of the period. Market growth can be attributed to the growing prevalence of gastrointestinal diseases such as Crohn's disease, ulcerative colitis, irritable bowel syndrome (IBS), and colorectal cancer, which drives the demand for diagnostic and therapeutic products.

  • Published: August 2024
  • Price: $ 4950
  • TOC Available:

• Medical Device Reprocessing Market by Type (Reprocessed Medical Devices), Device Category (Critical- Devices, Semi-Critical Devices, Non-Critical Devices), Application (Cardiology, Gynecology, Gastroenterology, Anesthesia) - Global Forecast to 2027

  The global medical device reprocessing market growth is primed to transition from USD 2.0 billion in 2022 to USD 3.9 billion by 2027, showcasing a strong CAGR of 13.7%. Growth in the market is mainly driven by the favorable regulatory standards for adoption of reprocessed medical devices by healthcare providers. On the other hand, the risk of infection from reprocessed medical devices may pose a threat to the market growth.

  • Published: July 2022
  • Price: $ 4950
  • TOC Available:

• Disposable Endoscopes Market by Type (GI Endoscopes, Urology Endoscopes, Laryngoscopes), Clinical Usage (Diagnostic, Surgical), Application (Urology, Gastroenterology, ENT Endoscopy), End User (Hospitals, ASCs, Clinics), Region - Global Forecast to 2030

  The global disposable endoscopes market, valued at US$0.84 billion in 2024, stood at US$0.95 billion in 2025 and is projected to advance at a resilient CAGR of 22.9% from 2024 to 2030, culminating in a forecasted valuation of US$2.67 billion by the end of the period.

  • Published: October 2025
  • Price: $ 4950
  • TOC Available:

• Fluoroscopy Equipment Market by Product (Fixed C-Arms, Fluoroscopy Systems (Remote Controlled, Patient Side), Mobile C-arms), and Application (Diagnostic (Cardio, Gastroenterology, Nephrology), Surgical (Ortho, Neuro, Cardio) - Global Forecast to 2025

  The Fluoroscopy Equipment Market is expected to grow from USD 5.9 billion in 2020 to USD 7.5 billion by 2025, at a CAGR of 4.8% during the forecast period. Major players operating in the fluoroscopy equipment market include Siemens Healthineers (Germany), GE Healthcare (US), Philips (Netherlands), Shimadzu Corporation (Japan), Ziehm Imaging (Germany), Canon Medical Systems (Japan), Hitachi (Japan), Carestream Health (US), Hologic (US), Lepu Medical Technology (China), Agfa-Gevaert Group (Belgium), and ADANI Systems (Belarus).

  • Published: December 2020
  • Price: $ 4950
  • TOC Available:

• Fluid Management Systems Market by Product Type )Systems (Standalone and Integrated Fluid Management Systems), Accessories), Application (Gastroenterology, General Surgery), End User, Key Stakeholder, Buying Criteria & Unmet Needs - Global Forecast to 2030

  The global Fluid Management Systems market, valued at US$12.5 billion in 2024, stood at US$13.3 billion in 2025 and is projected to advance at a resilient CAGR of 7.0% from 2025 to 2030, culminating in a forecasted valuation of US$18.6 billion by the end of the period. The fluid management systems market is driven by the increasing prevalence of chronic kidney disease, urological disorders, and gastrointestinal conditions that require advanced treatment solutions.

  • Published: September 2025
  • Price: $ 4950
  • TOC Available:

• Biopsy Devices Market by Product (Core needle biopsy (Automatic, Disposable), Technology (Ultrasound,stereotactic), Application (Oncology, Gastroenterology, Bone & Bone marrow biopsy), End User (Diagnostic imaging centres) - Global Forecast to 2030

  The global biopsy devices market, valued at US$6.86B in 2023, is forecasted to grow at a 7.2% CAGR, reaching US$7.27B by 2024 and US$11.01B by 2030. The rising prevalence of cancer. Additionally the increasing preference for minimally invasive surgeries. Moreover, the improved reimbursement policies is likely to promote the growth of biopsy device market.

  • Published: March 2025
  • Price: $ 4950
  • TOC Available:

• Oral Proteins & Peptides Market by Molecule (Semaglutide, Linaclotide, Calcitonin), Drug Class (GLP-1, GPE, CGRP), Therapeutic Area (Nephrology, Gastroenterology, Genetic, CNS, Obesity, Diabetes), Formulation (Tablet, Capsule) - Global Forecast to 2030

  The global oral proteins and peptides market, valued at US$8.07 billion in 2024, stood at US$9.31 billion in 2025 and is projected to advance at a resilient CAGR of 16.4% from 2025 to 2030, culminating in a forecasted valuation of US$19.93 billion by the end of the period. This growth is driven by several factors, including the rising prevalence of chronic diseases such as diabetes, gastrointestinal disorders, and kidney diseases.

  • Published: February 2025
  • Price: $ 4950
  • TOC Available:

• NEXT
• LAST

Records 1 to 10 of 50